´óÏó´«Ã½

Home
Department of Clinical Medicine

News archive for Department of Clinical Medicine

The 11th CCBIO Annual Symposium was this time enlarged with a generous time frame and two overnight stays, May 8-11, 2023. Although there was an option for online attendance, only 14 participants chose to attend online, and the rest of the total of 235 chose to enjoy the company of colleagues and the informal and mutually fertilizing scientific crosstalk in the breaks and the evenings.
This winter/spring, three of CCBIO's students got the opportunity to have research stays at different labs of the Vascular Biology Program in Boston, through CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Camilla Tvedt Ekanger, Medical Student Research Program student Amalie Bark Kvamme and PhD Candidate Ole Vidhammer Bjørnstad are now back... Read more
A new research project at the Department of Clinical Medicine (K1) aims to tailor treatment to children and adolescents living with chronic kidney disease. The Norwegian Research Council has provided NOK 12 million in support for the project. 
May 20 was the Clinical Trials Day, which arrives each May 20 as an opportunity for the clinical research community to pause in reflection, recognition, and admiration of all that has been accomplished thanks to clinical trials and the people behind them. The Norwegian Parkinson's Association took the opportunity to launch a short video, where Neuro-SysMed contributes with Professor Tzoulis... Read more
Get the latest news from Neuro-SysMed in our newsletters!
The research group of Professor Daniela Costea is currently engaged in a DIKU/NORPART funded collaboration project with partners in Tanzania, establishing immunohistochemistry for p16 as a method for more precise diagnostic of head and neck cancers (HNC). CCBIO has just had a visit from Tanzania, and Professor Costea has just returned from a 2 week stay in Dar Es Salaam where she worked with... Read more
The INTPART-II Flagship-course CCBIO907 Cancer-Related Vascular Biology took place in Bergen March 24th to March 31st 2023, with fortunate students from UiB and a couple of visiting students from abroad who got the opportunity to learn from and connect with excellent Harvard Medical School faculty on campus in Bergen.
CCBIO would like to highlight recent publications in high impact journals.
Acute myeloid leukemia is an aggressive blood cancer with poor survival. Younger and otherwise healthy patients undergo severe chemotherapy, often accompanied by stem cell transplant, even though it is difficult to predict who will benefit from the treatment. Now, a simple blood test can measure whether the patient's cancer will respond to chemotherapy. If the chemo has no effect, critical weeks... Read more
The Norwegian Cancer Society has a new funding program, the Norwegian Cancer Society Pioneer Projects, which supports early-stage exploration of novel and innovative ideas with potential for breaking new grounds in cancer research. CCBIO Associate Investigator Carina Strell just got the news that she is awarded with funding from this program for her project "ImSignal – Mapping active immune... Read more
Professor Arne Östman in CCBIO's International Faculty receives financial support from the Western Norway regional health authorities Helse Vest in their 2023 allocation. His project "Novel biomarkers and combination treatments for ER+ breast cancer" receives NOK 1.500.000 in the first year.
November 26, the regional health authorities Helse Vest announced their funding for 2023, allocating 182 million NOK to 57 new projects, and renewed support to 160 fellows and projects. Among the new projects, CCBIO PI Oddbjørn Straume receives open project support for his project "Targeting AXL to improve immunotherapy: Deep clinical biomarker analysis for precision medicine." The funding... Read more
Professor Charalampos Tzoulis receives $300,000 (3MNOK) from the prestigious Michael J. Fox Foundation.
CCBIO hosted the 6th SCANPATH meeting – Scandinavian Seminar on Translational Pathology – on November 14 and 15 at Solstrand Hotel, close to Bergen (Norway). Top Scandinavian tumor pathologist and pre-clinical scientists came to present and discuss tissue-based studies of tumor mechanisms and biomarker mapping. SCANPATH is a well-established annual forum and has been a successful CCBIO initiative... Read more
The regional health authorities, Helse Vest, just released their latest funding results in which 7 Neuro-SysMed projects will receive funding for a total of ~26 Million NOK. This will secure support for important clinical treatment research focusing on multiple sclerosis (MS), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and dementia.
Christiane Helgestad Gjerde, PhD candidate in the Bjørge and McCormack groups at CCBIO and the Department of Clinical Science, was awarded with the Kolbjørn Brambani Cancer Research Grant 2022 at the Onkologisk Forum meeting November 17.
Helse Vest, the regional health authorities, has recently announced their 2022 awards, where Kjell-Morten Myhr received the Research Award 2022 for his outstanding work on Multiple Sclerosis research.

Pages